Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Yang BF, Jin J, He XR, Yang ZH, Qian X, Tong YQ, Ke CX, Li ZH, Li ZX, Zhong LF, Gan ZH, Zhang XF, Zeng Y. Yang BF, et al. Among authors: zhang xf. Expert Rev Vaccines. 2024 Dec 25. doi: 10.1080/14760584.2024.2446288. Online ahead of print. Expert Rev Vaccines. 2024. PMID: 39720838
Advances in diagnostic assays for Clostridioides difficile infection in adults.
Liu DA, Chen S, Hu R, Qiu Y, Chen K, Xu Y, Yuan J, Zhang X, Li X. Liu DA, et al. Among authors: zhang x. Front Cell Infect Microbiol. 2024 Dec 10;14:1492511. doi: 10.3389/fcimb.2024.1492511. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39720791 Free PMC article. Review.
182,259 results
You have reached the last available page of results. Please see the User Guide for more information.